Endocrinology, Vol 130, 2413-2419, Copyright © 1992 by Endocrine Society

ARTICLES

The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates

AC Levine, M Ren, GK Huber and A Kirschenbaum
Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029.

Stromal enlargement plays a key role in the development of benign prostatic hypertrophy in humans. Human prostatic fibroblasts were obtained from fetal and adult prostates and characterized as to their androgen and estrogen receptor status and growth in response to dihydrotestosterone (DHT), estradiol (E2), hydroxyflutamide (OH-FLU), hydrocortisone, basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF). In addition, the ability of hormones and growth factors to induce the messenger RNA (mRNA) for the c-fos protooncogene was assessed as a measure of the early, direct effects of these compounds on cellular proliferation. Nuclear androgen receptors were demonstrable by immunocytochemistry in both fetal and adult cells. Nuclear estrogen receptor staining was negative. Neither E2 nor hydrocortisone increased cellular proliferation. Both EGF and bFGF did increase cellular growth. DHT (10(-8)-10(-7) M) had a significant stimulatory effect on cell growth only in serum-free media. OH-FLU addition enhanced DHT induced proliferation. Changing the media during the course of the experiment obliterated the stimulatory effect of DHT. Both EGF (10 ng/ml) and bFGF (20 ng/ml) increased the mRNA for the c- fos protooncogene. DHT (10(-7) M) did not induce the mRNA for c-fos. We conclude that EGF, bFGF, and DHT (especially in combination with OH- FLU) increase the proliferation of human prostatic fetal and adult fibroblasts in vitro. E2 has no effect on fibroblast proliferation. The stimulatory effects of EGF and bFGF are direct, whereas the effect of DHT appears to be indirect, possibly mediated via the increased production and/or secretion of growth factors.

This article has been cited by other articles:

				C. K M Ho, J. Nanda, K. E Chapman, and F. K Habib Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen J. Endocrinol., June 1, 2008; 197(3): 483 - 491. [Abstract] [Full Text] [PDF]

				A. Kirschenbaum, X.-H. Liu, S. Yao, G. Narla, S. L. Friedman, J. A. Martignetti, and A. C. Levine Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones Carcinogenesis, February 1, 2006; 27(2): 216 - 224. [Abstract] [Full Text] [PDF]

				H. Maeda, K. Kumagai, F. Konishi, Y. Katayama, K. Hiyama, S. Ishioka, and M. Yamakido Successful treatment of arthralgia with tamoxifen citrate in a patient with pachydermoperiostosis Rheumatology, October 1, 2000; 39(10): 1158 - 1159. [Full Text] [PDF]

				A. C. Levine, X.-H. Liu, P. D. Greenberg, M. Eliashvili, J. D. Schiff, S. A. Aaronson, J. F. Holland, and A. Kirschenbaum Androgens Induce the Expression of Vascular Endothelial Growth Factor in Human Fetal Prostatic Fibroblasts Endocrinology, November 1, 1998; 139(11): 4672 - 4678. [Abstract] [Full Text] [PDF]

				N. Itoh, U. Patel, A. S. Cupp, and M. K. Skinner Developmental and Hormonal Regulation of Transforming Growth Factor-{beta}1 (TGF{beta}1), -2, and -3 Gene Expression in Isolated Prostatic Epithelial and Stromal Cells: Epidermal Growth Factor and TGF{beta} Interactions Endocrinology, March 1, 1998; 139(3): 1378 - 1388. [Abstract] [Full Text] [PDF]

				S. J. Padayatty, M. Marcelli, T. C. Shao, and G. R. Cunningham Lovastatin-Induced Apoptosis in Prostate Stromal Cells J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1434 - 1439. [Abstract] [Full Text] [PDF]